Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction Between Efavirenz and Antituberculosis Drug Therapy Through Mechanism-Based Inactivation of CYP2A6

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02532-14

Related search